Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Eli Lilly Corp. | 75 | 0 | 13 | 0 | €819.60 | €831.01 | 1.392% |
| Vertex Pharmaceuticals Inc. | 59 | 2 | 2 | 0 | €426.85 | €450.36 | 5.509% |
| Regeneron Pharmaceuticals Inc. | 48 | 1 | 4 | 0 | €1,032.5 | €1,087.6 | 5.333% |
| Insmed Inc. | 46 | 0 | 2 | 0 | €65.50 | €77.15 | 17.786% |
| Alnylam Pharmace. | 44 | 0 | 4 | 0 | €246.10 | €275.35 | 11.887% |
| Neurocrine Bioscience | 42 | 0 | 5 | 0 | €107.90 | €155.89 | 44.476% |
| Johnson & Johnson | 40 | 1 | 4 | 0 | €149.76 | €193.85 | 29.444% |
| Intra-Cellular Therapies Inc. | 35 | 0 | 5 | 0 | €68.00 | €85.00 | 25.000% |
| Acadia Pharmaceuticals | 36 | 1 | 1 | 0 | €14.72 | €29.92 | 103.299% |
| Cytokinetics Inc. | 35 | 1 | 5 | 0 | €50.50 | €83.13 | 64.616% |
| AbbVie Inc. | 34 | 0 | 1 | 0 | €174.54 | €180.90 | 3.646% |
| Jazz Pharmaceuticals plc | 32 | 0 | 3 | 0 | €98.66 | €183.41 | 85.906% |
| Merck & Co. Inc. | 32 | 1 | 2 | 0 | €107.00 | €126.38 | 18.112% |
| BioMarin Pharmaceutical Inc. | 29 | 0 | 12 | 0 | €64.06 | €100.74 | 57.256% |
| Amgen Inc. | 27 | 0 | 0 | 0 | €301.40 | €304.82 | 1.134% |
| United Therapeutics | 28 | 1 | 3 | 0 | €308.40 | €315.21 | 2.208% |
| Ultragenyx Pharmaceutical Inc. | 28 | 1 | 3 | 0 | €51.50 | €84.74 | 64.551% |